Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-016-3866-0
Published Online: 2016-06-20
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tiwari, Shruti R.
Mishra, Prasun
Raska, Paola
Calhoun, Benjamin
Abraham, Jame
Moore, Halle
Budd, G. Thomas
Fanning, Alicia
Valente, Stephanie
Stewart, Robyn
Grobmyer, Stephen R.
Montero, Alberto J.
License valid from 2016-06-20